Biodesix Inc (BDSX)

$1.15 +0.01 (0.88%)
Market Cap 167.29M
Revenue (ttm) 49.09M
Net Income (ttm) -52.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -106.23%
Debt to Equity Ratio 1.30
Volume 195,600
Avg Vol 509,202
Day's Range N/A - N/A
Shares Out 145.47M
Stochastic %K 13%
Beta 1.10
Analysts Strong Sell
Price Target $3.10

Latest News on BDSX

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

Jan 10, 2025, 6:00 AM EST - 8 days ago

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Jan 7, 2025, 6:00 AM EST - 11 days ago

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript

Nov 1, 2024, 3:29 PM EDT - 2 months ago

Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript

Biodesix Announces Third Quarter 2024 Results and Highlights

Nov 1, 2024, 6:00 AM EDT - 2 months ago

Biodesix Announces Third Quarter 2024 Results and Highlights

Biodesix to Participate in Three Investor Conferences in November

Oct 29, 2024, 6:00 AM EDT - 2 months ago

Biodesix to Participate in Three Investor Conferences in November

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Oct 18, 2024, 6:00 AM EDT - 3 months ago

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

Oct 7, 2024, 6:00 AM EDT - 3 months ago

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

Biodesix to Present at Two Investor Conferences in September

Sep 5, 2024, 6:00 AM EDT - 4 months ago

Biodesix to Present at Two Investor Conferences in September

Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 8:52 PM EDT - 5 months ago

Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript

Biodesix Announces Second Quarter 2024 Results and Highlights

Aug 7, 2024, 4:01 PM EDT - 5 months ago

Biodesix Announces Second Quarter 2024 Results and Highlights

Biodesix to Present at Canaccord Genuity's 44th Annual Growth Conference

Aug 6, 2024, 6:00 AM EDT - 5 months ago

Biodesix to Present at Canaccord Genuity's 44th Annual Growth Conference

Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 24, 2024, 6:00 AM EDT - 6 months ago

Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024

Biodesix Named to Inc. Magazine's 2024 “Best Workplaces”

Jun 18, 2024, 8:13 AM EDT - 7 months ago

Biodesix Named to Inc. Magazine's 2024 “Best Workplaces”

Biodesix to Participate in Two Investor Conferences in June

May 28, 2024, 6:00 AM EDT - 8 months ago

Biodesix to Participate in Two Investor Conferences in June

Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting

May 21, 2024, 6:00 AM EDT - 8 months ago

Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting

Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript

May 10, 2024, 1:06 AM EDT - 9 months ago

Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

May 8, 2024, 4:01 PM EDT - 9 months ago

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference

May 7, 2024, 6:00 AM EDT - 9 months ago

Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference

Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 24, 2024, 6:00 AM EDT - 9 months ago

Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024

Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting

Apr 9, 2024, 5:00 PM EDT - 10 months ago

Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting

Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement

Apr 5, 2024, 7:17 AM EDT - 10 months ago

Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement

Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center

Mar 25, 2024, 6:00 AM EDT - 10 months ago

Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center

Biodesix, Inc. (BDSX) Q4 2023 Earnings Call Transcript

Mar 1, 2024, 12:35 PM EST - 11 months ago

Biodesix, Inc. (BDSX) Q4 2023 Earnings Call Transcript

Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights

Mar 1, 2024, 6:00 AM EST - 11 months ago

Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights

Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference

Feb 26, 2024, 6:00 AM EST - 11 months ago

Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference

Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024

Feb 16, 2024, 6:00 AM EST - 1 year ago

Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

Nov 14, 2023, 6:00 AM EST - 1 year ago

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

Biodesix, Inc. (BDSX) Q3 2023 Earnings Call Transcript

Nov 11, 2023, 1:24 PM EST - 1 year ago

Biodesix, Inc. (BDSX) Q3 2023 Earnings Call Transcript

Biodesix to Participate in Two Upcoming Investor Conferences in November

Nov 9, 2023, 6:00 AM EST - 1 year ago

Biodesix to Participate in Two Upcoming Investor Conferences in November

Biodesix Announces Third Quarter 2023 Results and Highlights

Nov 7, 2023, 4:01 PM EST - 1 year ago

Biodesix Announces Third Quarter 2023 Results and Highlights

Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023

Oct 24, 2023, 6:00 AM EDT - 1 year ago

Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023

Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting

Oct 3, 2023, 6:00 AM EDT - 1 year ago

Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting

Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer

Sep 7, 2023, 6:00 AM EDT - 1 year ago

Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer

Biodesix to Participate in Two Upcoming Investor Conferences in September

Sep 5, 2023, 6:00 AM EDT - 1 year ago

Biodesix to Participate in Two Upcoming Investor Conferences in September

Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer

Aug 22, 2023, 6:00 AM EDT - 1 year ago

Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer

Biodesix, Inc. (BDSX) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 6:43 PM EDT - 1 year ago

Biodesix, Inc. (BDSX) Q2 2023 Earnings Call Transcript

Biodesix Announces Second Quarter 2023 Results and Highlights

Aug 7, 2023, 4:01 PM EDT - 1 year ago

Biodesix Announces Second Quarter 2023 Results and Highlights

Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference

Aug 1, 2023, 6:00 AM EDT - 1 year ago

Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference

Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023

Jul 24, 2023, 6:00 AM EDT - 1 year ago

Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023

Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules

Jul 12, 2023, 6:00 AM EDT - 1 year ago

Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules

Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services

Jul 6, 2023, 9:11 AM EDT - 1 year ago

Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services

Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier

Jun 27, 2023, 6:00 AM EDT - 1 year ago

Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier

Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting

Jun 1, 2023, 6:00 AM EDT - 1 year ago

Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting

Biodesix to Participate in William Blair's 43rd Annual Growth Stock Conference

May 31, 2023, 6:00 AM EDT - 1 year ago

Biodesix to Participate in William Blair's 43rd Annual Growth Stock Conference

Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing

May 25, 2023, 6:00 AM EDT - 1 year ago

Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing

Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors

May 24, 2023, 6:00 AM EDT - 1 year ago

Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors

Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference

May 18, 2023, 7:00 AM EDT - 1 year ago

Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference

Biodesix, Inc. (BDSX) Q1 2023 Earnings Call Transcript

May 14, 2023, 11:53 AM EDT - 1 year ago

Biodesix, Inc. (BDSX) Q1 2023 Earnings Call Transcript

Biodesix Announces First Quarter 2023 Results and Highlights

May 11, 2023, 4:01 PM EDT - 1 year ago

Biodesix Announces First Quarter 2023 Results and Highlights

Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023

Apr 27, 2023, 6:00 AM EDT - 1 year ago

Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023